首页> 外文期刊>Experimental and clinical transplantation >Impact of Donor and Recipient Age on Allograft Tolerance
【24h】

Impact of Donor and Recipient Age on Allograft Tolerance

机译:供体和接受者年龄对同种异体移植耐受性的影响

获取原文
           

摘要

The elderly represent the fastest growing segment of the population with end-stage organ disease and the use of aged grafts increased exponentially. Since aging of the immune system, or "immuno-senscence" is generally associated with weaker immune responses, one might expect the elderly to be less reactive against transplanted organs than younger patients and therefore to show better results in terms of transplant outcome. Paradoxically, however, experimental studies and clinical data of organ transplantation show that old age of either the recipient or the donor is associated with poorer outcomes. On the other hand transplant tolerance is easier to be induced in the neonatal period. One potential reason for this discrepancy may lie in the effects of immuno-senescence on the induction of tolerance. While the impact of aging on acute and chronic allograft rejection has been extensively studied, its role on establishing transplant tolerance is not well known. Since tolerance is an active process, and not just the absence of an immune response, the immunologic changes associated with the aging process may interfere with graft survival. In experimental and clinical trans-plantation, most successful tolerance induction protocols have been tested on young individuals, using grafts from young donors. However, some experiments that have utilized aged animals have demonstrated resistance to tolerance induction. Extrapolation of these results to humans suggests that protocols for clinical tolerance induction may not be effective in the elderly and may need to be revised for this population. The resistance to achieving immunological tolerance with aging is complex and multifactorial. Here, we review the age associated changes that may interfere with immunologic tolerance. Understanding this phenomenon may help in developing novel therapeutic approaches to reverse the crucial dysfunctions of the aging immune system and achieve effective tolerance regimens for the elderly.
机译:老年人是患有晚期器官疾病的人口中增长最快的部分,并且老化的移植物的使用呈指数增长。由于免疫系统的衰老或“免疫感觉”通常与较弱的免疫反应有关,因此人们可能希望老年人比年轻患者对移植器官的反应性更低,因此在移植结果方面显示出更好的结果。然而,自相矛盾的是,实验研究和器官移植的临床数据表明,受体或供体的老年都与较差的预后有关。另一方面,在新生儿期更容易引起移植耐受。这种差异的一个潜在原因可能是免疫衰老对耐受性诱导的影响。尽管已经对衰老对急性和慢性同种异体移植排斥的影响进行了广泛研究,但其在建立移植耐受性中的作用尚不清楚。由于耐受是一个活跃的过程,而不仅仅是缺乏免疫反应,与衰老过程相关的免疫学变化可能会干扰移植物的存活。在实验和临床移植中,已经使用年轻供体的移植物对年轻人进行了最成功的耐受诱导方案的测试。但是,一些利用成年动物的实验证明了对耐受诱导的抗性。将这些结果推算给人类表明,临床耐受诱导方案在老年人中可能无效,因此可能需要对该人群进行修订。随着年龄的增长,获得免疫耐受的抵抗力是复杂和多因素的。在这里,我们回顾了与年龄相关的变化,这些变化可能会干扰免疫耐受。了解这种现象可能有助于开发新颖的治疗方法,以扭转衰老的免疫系统的关键功能障碍,并为老年人提供有效的耐受方案。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号